Skip to main content
Skip to main navigation menu
Skip to site footer
Open Menu
About
Sobre o periódico
Privacy Statement
Política editorial
Indexadores
Editorial Team
Current Issue
Older Issues
Notícias
Submissions
Contact
Search
Register
Login
Home
/
Archives
/
Vol. 9 No. 2 (2017)
Vol. 9 No. 2 (2017)
Published:
2017-08-20
Full Issue
PDF (Português (Brasil))
Artigos
Cost-effectiveness analysis of continuous versus intermittent renal replacement therapy for critically ill acute kidney injury patients under the perspective of the Brazilian Private Healthcare System
Manuel Ramirez, Maristela Costa, Milena Costa
152-158
PDF (Português (Brasil))
Number needed to treat (NNT) comparison between the association of cobimetinib and vemurafenib among other treatment options for metastatic melanoma with brafv600 mutation
Rodrigo Shimabukuro Ho, Camila Souza, Jairo Simões, Marcia Regina Alves
159-163
PDF (Português (Brasil))
Cost-effectiveness of trimetazidine for stable angina treatment in non-responder diabetics after beta blockers, nitrates and calcium channel blockers
Luiz Antonio Cesar, Camila Pepe, Roberta Arinelli
164-176
PDF (Português (Brasil))
Indicators for economic evaluation of drug hospital´'s acquisition
Patrícia Mastroianni, Alice Oliveira, Tales Nadai, Rosa Camila Lucchetta
177-184
PDF (Português (Brasil))
Electronic health record: contributions to new organizational models in the public health sector
Pedro Miguel Correia, Helena Bernardes
185-197
PDF (Português (Brasil))
Bioequivalence evaluation of two desvenlafaxine succinate monohydrate formulations 50-mg extended-release coated tablet administered in fasted and fed conditions in healthy male and female volunteers
José Predrazzoli-Júnior, Silvana Calafati, Edvaldo Coelho, Maira Eduarda Zanin, Florência Duarte, Flávia Bonetti, Vanessa Dutra, Juliana Loschi, Gabriela Cristina Lima, Marcelo Davanço, Daniel Campos
198-206
PDF (Português (Brasil))
Economic evaluation of antipsychotics for the treatment of schizophrenia: a systematic review
André Santos, Isabella Godói, Carlos Eduardo Vidal, Cristina Ruas
207-228
PDF
Economic evidence of health interventions under the perspective of the Brazilian public health system: why and what for can we produce it and use it?
Fabiola Vieira
229-236
PDF (Português (Brasil))
Comment on the article: "Cost-effectiveness threshold: is it needed in Brazil?"
André Santos, Cristina Ruas
237-239
PDF (Português (Brasil))
Make a Submission
Make a Submission
Keywords
Block title
A Saúde Suplementar e sua atuação junto ao Sistema Único de Saúde: uma revisão integrativa
40
Aedes aegypti e sociedade: o impacto econômico das arboviroses no Brasil
38
Custos com os cuidados da atrofia muscular espinhal 5q (AME-5q) no Brasil
28
Impactos da insuficiência cardíaca no sistema de saúde e previdenciário brasileiro: qual é o custo da doença?
21
Custo hospitalar para tratamento da fratura aguda do fêmur por osteoporose em dois hospitais-escola conveniados ao Sistema Único de Saúde
21
Information
For Readers
For Authors
For Librarians
Navegar
Instagram
LinkedIn
Language
English
Português (Brasil)
Current Issue